Abstract
Background and Clinical Significance: The objective of this case study is to report on the clinical outcomes of a hard-to-heal posterior upper-thigh pressure ulcer when managed with a sterile human amniotic membrane tissue allograft. Case Presentation: Retrospective case data of a patient who received five applications of barrera(TM) between February 2024 and April 2024 as part of their care regimen for a chronic pressure ulcer was obtained from a single wound care group. Data evaluated consisted of past patient medical history, concomitant medications, previous wound care treatments, wound type, wound size, adjunctive wound therapies and wound outcomes post allograft. The chronic pressure ulcer, measuring at 10.5 cm(2) prior to allograft application, achieved complete closure at the last observation post the final, fifth application. Wound size attenuation was seen as early as 1 week post initial allograft application. No adverse events or complications related to barrera(TM) were observed. Conclusions: Results suggest that the application of dual-layer allografts in the context of chronic ulcers may represent a safe and effective wound management utility.